BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 14, 2007
View Archived Issues
VioQuest cancer agents progress through early studies
Read More
Docetaxel/telatinib combination shows promise in cancer patients
Read More
Lorus reports first quarter results for fiscal 2008
Read More
HNE scavengers may have potential in AD
Read More
Shire licenses Amigal, Plicera and AT-2220 from Amicus for markets outside of the U.S.
Read More
Preliminary study results show FG-4592 well tolerated in CKD anemia
Read More
Ferric carboxymaltose injection shows promise in non-dialysis-dependent CKD anemia
Read More
Recent developments for Pharmaxis' Bronchitol and Aridol
Read More
Post hoc analyses of IDEAL, SPARCL studies show additional benefits of atorvastatin
Read More
Phase I study results for ARC-1779 in healthy volunteers available
Read More
LY-518674 increases apo A-I production but not HDL cholesterol in metabolic syndrome patients
Read More
Phoqus presents update on clinical trial program for Chronocort
Read More
TB Alliance conducts clinical trials on moxifloxacin and PA-824 for TB
Read More
Santhera initiates FJORD clinical trial of JP-1730 for dyskinesia in Parkinson's disease
Read More
Pharmexa reports positive preliminary results from the HVTN 064 phase I trial of EP-1043
Read More
Antisense initiates collaborative research program to examine ATL-1101 for prostate cancer
Read More
Vivus initiates EQUIP phase III trial of Qnexa in morbidly obese patients
Read More
Seattle Genetics initiates phase IIb clinical trial of SGN-33 for acute myeloid leukemia
Read More
Expression Genetics receives grant from the National Cancer Institute to develop EGEN-001
Read More
Elite concludes special protocol assessment with FDA for phase III trial of ELI-216
Read More
KeyNeurotek initiates phase I study of cannabinoid receptor agonist KN-38-7271 for stroke
Read More
Santhera presents an update on its clinical development portfolio
Read More
FDA accepts Akesis' IND application for phase IIa study of AKP-020 for type 2 diabetes
Read More
AtheroGenics discontinuing 300 mg dose of AGI-1067 in ANDES trial
Read More
FDA requests additional data for Synvisc-One marketing application
Read More
Short-acting sedative-hypnotic presented at Neuroscience meeting
Read More
First marketing authorization application submitted for Advexin
Read More
Na+ and Ca2+ channel-blocking antiepileptic with a promising pharmacological profile
Read More
Recent Tibotec and Pfizer patents report new therapeutic agents for HIV infection
Read More
Novel agents for cardiovascular disorders disclosed in recent patents
Read More
